ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway

被引:12
|
作者
Xin, Ting [1 ]
Lv, Wei [1 ]
Liu, Dongmei [1 ]
Jing, Yongle [1 ]
Hu, Fang [1 ]
机构
[1] Tianjin First Cent Hosp, Dept Cardiol, Tianjin 300192, Peoples R China
来源
AGING-US | 2020年 / 12卷 / 12期
关键词
ROCK1; LATS2; JNK; NSCLC; apoptosis; OXIDATIVE STRESS; MITOCHONDRIAL FISSION; APOPTOSIS; INJURY; HIPPO; AXIS; JNK; CARCINOMA; MITOPHAGY; YAP;
D O I
10.18632/aging.103386
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Rho-associated kinase 1 (ROCK1) regulates tumor metastasis by maintaining cellular cytoskeleton homeostasis. However, the precise role of ROCK1 in non-small-cell lung cancer (NSCLC) apoptosis remains largely unknown. In this study, we examined the function of ROCK1 in NSCLS survival using RNA interference-mediated knockdown. Our results showed that ROCK1 knockdown reduced A549 lung cancer cell viability in vitro . It also inhibited A549 cell migration and proliferation. Transfection of ROCK1 siRNA was associated with increased expression of large tumor suppressor kinase 2 (LATS2) and c-Jun N-terminal kinase (JNK). Moreover, ROCK1 knockdown-induced A549 cell apoptosis and inhibition of proliferation were suppressed by LATS2 knockdown or JNK inactivation, suggesting that ROCK1 deficiency triggers NSCLC apoptosis in a LATS2-JNK pathway- dependent manner. Functional analysis further demonstrated that ROCK1 knockdown dysregulated mitochondrial dynamics and inhibited mitochondrial biogenesis. This effect too was reversed by LATS2 knockdown or JNK inactivation. We have thus identified a potential pathway by which ROCK1 downregulation triggers apoptosis in NSCLC by inducing LATS2-JNK-dependent mitochondrial damage.
引用
收藏
页码:12160 / 12174
页数:15
相关论文
共 50 条
  • [31] Non-small-cell lung carcinoma: role of the Notch signaling pathway
    Barse, Levi
    Bocchetta, Maurizio
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 43 - 53
  • [32] Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway
    Guo, Xiaobin
    Zhu, Xiaoming
    Zhao, Limin
    Li, Xiao
    Cheng, Dongjun
    Feng, Keqing
    TUMOR BIOLOGY, 2017, 39 (03) : 1 - 10
  • [33] Knockdown GTSE1 enhances radiosensitivity in non-small-cell lung cancer through DNA damage repair pathway
    Lei, Xiao
    Du, Lehui
    Zhang, Pei
    Ma, Na
    Liang, Yanjie
    Han, Yanan
    Qu, Baolin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (09) : 5162 - 5167
  • [34] Targeting the eicosanoid pathway in non-small-cell lung cancer
    Horn, Leora
    Backlund, Michael
    Johnson, David H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (06) : 675 - 688
  • [35] ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma
    Busch, S. E.
    Moser, R. D.
    Gurley, K. E.
    Kelly-Spratt, K. S.
    Liggitt, H. D.
    Kemp, C. J.
    ONCOGENE, 2014, 33 (20) : 2665 - 2673
  • [36] ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma
    S E Busch
    R D Moser
    K E Gurley
    K S Kelly-Spratt
    H D Liggitt
    C J Kemp
    Oncogene, 2014, 33 : 2665 - 2673
  • [37] Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non-Small-Cell Lung Cancer
    Chen, Yuhchyau
    Nowak, Irena
    Huang, Jiaoti
    Keng, Peter C.
    Sun, Hongliang
    Xu, Haodong
    Wei, Gang
    Lee, Soo Ok
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (01) : 50 - 58
  • [38] NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling
    Xu, ZheYuan
    Wang, Yang
    Xiong, Jian
    Cui, FengXian
    Wang, Lan
    Peng, Hao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (04) : 3886 - 3893
  • [39] Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer: Evidence to Date
    Bylicki, Olivier
    Paleiron, Nicolas
    Assie, Jean-Baptiste
    Chouaid, Christos
    ONCOTARGETS AND THERAPY, 2020, 13 : 5691 - 5706
  • [40] Agrimonolide Inhibits the Malignant Progression of Non-small Cell Lung Cancer and Induces Ferroptosis through the mTOR Signaling Pathway
    Zhang, Xiaoling
    Cai, Wei
    Yan, Yiguang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024, 24 (18) : 1371 - 1381